EBS - Emergent Biosolutions Inc
Emergent Biosolutions Inc Logo

EBS - Emergent Biosolutions Inc

https://www.emergentbiosolutions.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHT). The company is headquartered in Gaithersburg, Maryland.

52W High
$12.73
52W Low
$4.02
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
2.04
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
2.89
Forward P/E (<15 better)
1.92
EV/EBITDA (<8 favorable)
2.34
EV/Revenue (<3 favorable)
0.99
P/S (TTM) (<3 favorable)
0.48
P/B (<3 favorable)
0.75
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
2.84%
Institutions (25–75% balanced)
70.03%
Shares Outstanding
53,351,000
Float
51,873,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
851,600,000
Gross Profit (TTM)
480,200,000
EPS (TTM)
2.62
Profit Margin (>10% good)
0.16%
Operating Margin (TTM) (higher better)
0.00%
ROE (TTM) (>15% strong)
0.30%
EPS YoY (Quarterly) (>10% good)
6.00
Revenue YoY (Quarterly) (>8% good)
-0.45
Momentum
Bearish momentum
Value
0.0296
Previous
0.0270
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025